General form of registration statement for all companies including face-amount certificate companies

Company Background (Details Narrative)

v2.4.0.8
Company Background (Details Narrative) (USD $)
 0 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 93 Months Ended 1 Months Ended 9 Months Ended 1 Months Ended
Feb. 07, 2014
Jan. 03, 2014
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2006
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2008
Dec. 31, 2007
Dec. 31, 2013
May 31, 2013
May 31, 2006
Common Stock [Member]
Dec. 31, 2006
Common Stock [Member]
May 31, 2006
Series C Preferred Stock [Member]
May 31, 2006
Preferred Series A [Member]
May 31, 2006
Preferred Series B [Member]
May 31, 2006
Series C Preferred Stock [Member]
Mar. 24, 2006
Series C Preferred Stock [Member]
Issuance of common stock, shares                                 9,447,100 9,447,100          
Issuance of preferred stock                                     13,859,324 [1] 14,440,920 [1] 11,113,544 [1]    
Issuance of preferred stock issued additional                                           704,225 [1] 704,225
Ownership interest               100.00%             100.00% 100.00%              
Proceeds from issuance of common stock and warrants $ 3,923,100                                            
Issuance of common shares for cash, Shares 6,276,960                                            
Warrants issued 6,276,960                                            
Warrant exercise price per share $ 0.625 $ 0.625           $ 0.625             $ 0.625                
Proceeds from issuance of notes payable   2,076,000           8,489,036                              
Aggregate principal amount of notes payable (issued Jan. 03, 2014) converted to common stock   2,076,000           8,489,036             8,489,036                
Outstanding principal notes repaid in full                       500,000 55,000                    
Shares of common stock issued upon conversion of notes payable   3,353,437           14,446,777                              
Warrants issued upon conversion of notes payable (issued Jan. 03, 2014)   3,321,600           14,446,777                              
Stock options cancelled 15,290,486                                            
Exercise price of cancelled option $ 0.07                                            
Stock options issued in substitution of cancelled options 6,889,555                                            
Stock options issued in substitution of cancelled options, price per share $ 0.155                                            
Additional stock options issued purchase number of common stock 20,867,266                                            
Additional stock options issued purchase number of common stock, price per share $ 0.625                                            
Net losses     1,880,394 1,348,340 15,186,393 2,849,861 4,104,289 4,361,165 2,543,390 1,879,940 3,948,021 1,451,711 6,700,148 7,908,993 32,897,657                
Deficit accumulated during the development stage     470,823   470,823        28,536,492                             
Cash in operating activities         $ 4,918,854 $ 2,955,988   $ 4,127,761 $ 1,159,237           $ 23,516,610                
[1] These shares were subsequently converted into 40,118,013 shares of Series A Preferred Stock.